As of the close on March 12, 2026, Weisi Medical (688580) closed at 62.84 yuan, up 0.54%, with a turnover rate of 3.54%, a trading volume of 33,900 lots, and a turnover of 210 million yuan.
Focus of the day
Transaction information summary fund flow
On March 12, the net outflow of main funds was 309,800 yuan, accounting for 0.15% of the total transaction volume; the net inflow of hot money funds was 7.2428 million yuan, accounting for 3.44% of the total transaction volume; the net outflow of retail funds was 6.933 million yuan, accounting for 3.29% of the total transaction volume.
Changes in equity shareholders Increase or decrease in shareholdings
On March 12, Weisi Medical issued an announcement "Weisi Medical: Nanjing Weisi Medical Technology Co., Ltd.'s Indicative Announcement Regarding Changes in Shareholders' Equity Touching the 1% Scale". Its shareholder Nanjing Zhida Venture Capital Center (Limited Partnership) announced in 2026 From February 9, 2026 to March 11, 2026, a total of 602,100 shares were reduced, accounting for 0.6287% of the company's current total share capital. During the change period, the stock price rose by 13.08%, closing at 62.5 yuan as of March 11.
Summary of company announcements
Nanjing Weisi Medical Technology Co., Ltd.’s indicative announcement regarding changes in shareholders’ equity touching the 1% mark
Wang Zhiyu, the controlling shareholder of Nanjing Weisi Medical Technology Co., Ltd., and its concerted person, Nanjing Zhida Venture Capital Center (Limited Partnership), reduced their holdings of 602,143 shares of the company through centralized bidding and block transactions from February 9 to March 11, 2026, accounting for 0.63% of the total share capital. After this equity change, the total shareholding ratio of Wang Zhiyu and persons acting in concert decreased from 46.51% to 45.88%, touching a 1% ratio change. This change did not lead to changes in the company's controlling shareholders and actual controllers, did not involve a tender offer, and was consistent with the previously disclosed shareholding reduction plan.
The above content is compiled by Securities Star based on public information and generated by an AI algorithm (Network Information No. 310104345710301240019) and does not constitute investment advice.
